Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C20H41N5O7 |
| Molecular Weight | 463.5688 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 13 / 13 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CN[C@@H]1[C@@H](O)[C@@H](O[C@H]2[C@H](N)C[C@H](N)[C@@H](O[C@H]3O[C@@H](CC[C@H]3N)[C@@H](C)N)[C@@H]2O)OC[C@]1(C)O
InChI
InChIKey=XUFIWSHGXVLULG-IDLVJFIQSA-N
InChI=1S/C20H41N5O7/c1-8(21)12-5-4-9(22)18(30-12)31-15-10(23)6-11(24)16(13(15)26)32-19-14(27)17(25-3)20(2,28)7-29-19/h8-19,25-28H,4-7,21-24H2,1-3H3/t8-,9-,10+,11-,12+,13+,14-,15-,16+,17-,18-,19-,20+/m1/s1
| Molecular Formula | C20H41N5O7 |
| Molecular Weight | 463.5688 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 13 / 13 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Gentamicin C2 together with epimer C2a is a part of the antibiotic of the aminoglycoside group, gentamicin. Gentamicin C2 has a methyl group in the 6′ position. Gentamicin is a broad-spectrum antibiotic that binds to the prokaryotic ribosome, inhibiting protein synthesis in susceptible bacteria. Gentamicin is bactericidal in vitro against Gram-positive and Gram-negative bacteria.
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:28:28 GMT 2025
by
admin
on
Mon Mar 31 18:28:28 GMT 2025
|
| Record UNII |
3P99H114B8
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C2363
Created by
admin on Mon Mar 31 18:28:28 GMT 2025 , Edited by admin on Mon Mar 31 18:28:28 GMT 2025
|
||
|
FDA ORPHAN DRUG |
513215
Created by
admin on Mon Mar 31 18:28:28 GMT 2025 , Edited by admin on Mon Mar 31 18:28:28 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
3P99H114B8
Created by
admin on Mon Mar 31 18:28:28 GMT 2025 , Edited by admin on Mon Mar 31 18:28:28 GMT 2025
|
PRIMARY | |||
|
25876-11-3
Created by
admin on Mon Mar 31 18:28:28 GMT 2025 , Edited by admin on Mon Mar 31 18:28:28 GMT 2025
|
PRIMARY | |||
|
C76150
Created by
admin on Mon Mar 31 18:28:28 GMT 2025 , Edited by admin on Mon Mar 31 18:28:28 GMT 2025
|
PRIMARY | |||
|
m5697
Created by
admin on Mon Mar 31 18:28:28 GMT 2025 , Edited by admin on Mon Mar 31 18:28:28 GMT 2025
|
PRIMARY | Merck Index | ||
|
28292
Created by
admin on Mon Mar 31 18:28:28 GMT 2025 , Edited by admin on Mon Mar 31 18:28:28 GMT 2025
|
PRIMARY | |||
|
C100093
Created by
admin on Mon Mar 31 18:28:28 GMT 2025 , Edited by admin on Mon Mar 31 18:28:28 GMT 2025
|
PRIMARY | |||
|
DTXSID9023093
Created by
admin on Mon Mar 31 18:28:28 GMT 2025 , Edited by admin on Mon Mar 31 18:28:28 GMT 2025
|
PRIMARY | |||
|
72397
Created by
admin on Mon Mar 31 18:28:28 GMT 2025 , Edited by admin on Mon Mar 31 18:28:28 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
SALT/SOLVATE -> PARENT |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |